Showing results 1 to 4 of 4
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
Androgen Receptor as an Emerging Feasible Biomarker for Breast Cancer Journal:Biomolecules | 2022 | 5 | ||
Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer Journal:International Journal of Molecular Sciences | 2022 | |||
Implications of Social Neuroscience for Learning Technology Research and Development Book:Mind, Brain and Technology: Learning in the Age of Emerging Technologies | 2019 | 35 | ||
Targeting CHK2 to reverse tamoxifen resistance by reducing BQ323636.1 in ER-positive breast cancer Proceeding/Conference:The Virtual New Zealand Breast Cancer Symposium, 2021 | 2021 |